Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yayoi Tada

Showing results (61-70 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Dermatology|September 5, 2025
Disease Impact and Burden of Psoriasis Vulgaris in Visible Body Areas in Japan: A Qualitative StudyKoki Endo, Yuko Higaki, Ami Cho, et al.
The Journal of Dermatology|March 1, 2011
Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgarisMasaru Karakawa, Mayumi Komine, Tomonori Takekoshi, et al.
Acta Dermato-Venereologica|June 25, 2010
Bullous amyloidosis mimicking bullous pemphigoid: usefulness of electron microscopic examinationAkihiko Asahina, Kazuko Hasegawa, Miyako Ishiyama, et al.
Journal of Dermatological Science|March 18, 2014
Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblastsZenshiro Tamaki, Yoshihide Asano, Masahide Kubo, et al.
The Journal of Dermatology|October 25, 2025
Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform DermatitisTeruo Shimizu, Masahiro Kamata, Hideya Uratsuji, et al.
Acta Dermato-Venereologica|March 16, 2016
Bullous Pemphigoid with Immunoglobulin G anti-LAD-1 Antibodies without Evident Erythema and Eosinophil InfiltrationTetsuya Ikawa, Yayoi Tada, Takamitsu Ohnishi, et al.
The Journal of Dermatology|December 26, 2015
Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 responseCarren S Hau, Naoko Kanda, Yayoi Tada, et al.
Dermatology and Therapy|January 1, 2023
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyStephen K Tyring, Phoebe Rich, Yayoi Tada, et al.
The American Journal of Pathology|April 16, 2013
CD19 expression in B cells regulates atopic dermatitis in a mouse modelKoichi Yanaba, Masahiro Kamata, Yoshihide Asano, et al.
The Journal of Dermatology|May 10, 2018
Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapyShinichi Imafuku, Min Zheng, Yayoi Tada, et al.
Pageof 26

Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Dermatology|September 5, 2025
Disease Impact and Burden of Psoriasis Vulgaris in Visible Body Areas in Japan: A Qualitative StudyKoki Endo, Yuko Higaki, Ami Cho, et al.
The Journal of Dermatology|March 1, 2011
Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgarisMasaru Karakawa, Mayumi Komine, Tomonori Takekoshi, et al.
Acta Dermato-Venereologica|June 25, 2010
Bullous amyloidosis mimicking bullous pemphigoid: usefulness of electron microscopic examinationAkihiko Asahina, Kazuko Hasegawa, Miyako Ishiyama, et al.
Journal of Dermatological Science|March 18, 2014
Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblastsZenshiro Tamaki, Yoshihide Asano, Masahide Kubo, et al.
The Journal of Dermatology|October 25, 2025
Combined Maxacalcitol/Betamethasone Butyrate Propionate Ointment Possesses Long-Term Sustained Effects of Inducing Regulatory T Cells and Downregulating the Th17 Response, Even After Discontinuation of Its Application in Imiquimod-Induced Psoriasiform DermatitisTeruo Shimizu, Masahiro Kamata, Hideya Uratsuji, et al.
Acta Dermato-Venereologica|March 16, 2016
Bullous Pemphigoid with Immunoglobulin G anti-LAD-1 Antibodies without Evident Erythema and Eosinophil InfiltrationTetsuya Ikawa, Yayoi Tada, Takamitsu Ohnishi, et al.
The Journal of Dermatology|December 26, 2015
Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 responseCarren S Hau, Naoko Kanda, Yayoi Tada, et al.
Dermatology and Therapy|January 1, 2023
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyStephen K Tyring, Phoebe Rich, Yayoi Tada, et al.
The American Journal of Pathology|April 16, 2013
CD19 expression in B cells regulates atopic dermatitis in a mouse modelKoichi Yanaba, Masahiro Kamata, Yoshihide Asano, et al.
The Journal of Dermatology|May 10, 2018
Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapyShinichi Imafuku, Min Zheng, Yayoi Tada, et al.
Pageof 26